NRAS and neoplasm: Three tumors (cases 2, 7, 12) presented KRAS12−13 PLLM or MUT in at least one of the tumor areas selected, but they also presented other KRAS or NRAS MUT or PLLM in other areas of the tumor (case 2) or in the same area (case 7, 12).